Healthcare Giant Invests $600 Million in New North Carolina Manufacturing Hub
Raleigh, Wednesday, 5 August 2026.
STERIS has committed $600 million to construct a major manufacturing facility in North Carolina. Marking the company’s largest single-site investment, the project will create 335 high-skilled jobs.
Investment Overview and Strategic Location
STERIS plc (NYSE: STE) has officially announced a capital expenditure of $600 million to construct a new Formulated Chemistries Center of Excellence [1]. The facility is designated for a site near the Raleigh-Durham Research Triangle in North Carolina, specifically supported by Lee County and the city of Sanford [1]. This investment represents the largest single-site manufacturing commitment in the company’s history, aimed at bolstering global supply chains for healthcare and life sciences sectors [1]. The project is expected to create approximately 335 jobs covering manufacturing, research and development, and distribution operations [1].
Operational Timeline and Facility Specifications
Construction of the 600,000 square-foot facility will proceed in phases, with operations projected to commence within 2 to 3 years, targeting a window between 2028 and 2029 [1]. Upon completion, STERIS plans to transition existing manufacturing and distribution activities from current sites in St. Louis, Missouri, and Plymouth, Minnesota, to the new North Carolina hub [1]. Distribution activities are scheduled to begin prior to full manufacturing capabilities, optimizing the logistics network for sterilization and disinfection solutions [1]. This timeline aligns with the company’s analysis of customer demand and existing facility constraints [1].
Financial Context and Market Position
As of August 4, 2026, STERIS plc held a market capitalization of $22.77 billion, with stock closing at $232.83 [2]. The announced $600 million investment constitutes a significant portion of the company’s valuation, calculated as 2.635 percent of the market cap [2]. The company operates within the Healthcare sector, specifically in Medical Devices, and generates revenue through a mix of consumable products, services, and capital equipment [2]. This expansion underscores a strategic focus on domestic U.S. manufacturing infrastructure amidst broader economic trends [1].
Executive and Regional Commentary
Dan Carestio, President and CEO of STERIS, stated that the investment follows extensive analysis to support long-term global growth and optimize the U.S. chemistries network [1]. North Carolina Governor Josh Stein noted that the project reinforces the state’s reputation as a powerhouse in the life sciences industry [1]. The initiative is backed by state and local entities, highlighting the collaborative economic development effort involved [1]. STERIS continues to monitor risks related to federal tax purposes and trade barriers that could impact financial performance [1].